Keyphrases
Human Epidermal Growth Factor Receptor 2 (HER2)
100%
Molecular Imaging
100%
Retargeting
100%
Pertuzumab
100%
Temporal Modulation
100%
Gastric Tumor
100%
Lovastatin
38%
NCI-N87 Cells
30%
Tumor Cells
23%
Endocytosis
23%
Cell Surface
15%
Molecular Therapy
15%
Pharmacological Modulation
15%
Therapeutic Target
7%
Clinically Significant
7%
Cell Membrane
7%
Cancer Cells
7%
Antibody Binding
7%
Tumor Detection
7%
Cellular Distribution
7%
Gastric Cancer
7%
Imaging Approach
7%
Targeted Imaging
7%
Tumor Uptake
7%
Tumor Therapeutics
7%
Cancer Xenograft
7%
Caveolae
7%
Non-interactive
7%
Tumor Biomarkers
7%
Anti-human Epidermal Growth Factor Receptor 2
7%
Conjugated Antibodies
7%
High Contrast Image
7%
Cholesterol-lowering Drugs
7%
Gastric Cancer Cells
7%
Temporal Enhancement
7%
Tetrazine
7%
Medicine and Dentistry
Molecular Imaging
100%
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Stomach Tumor
100%
Pertuzumab
100%
Lovastatin
35%
Tumor Cell
21%
Endocytosis
21%
Neoplasm
14%
In Vitro
14%
Cancer Cell
14%
Cell Surface
14%
Stomach Cancer
14%
Positron Emission Tomography
7%
Dimer
7%
Radioactive Tracer
7%
Cell Membrane
7%
Internalization
7%
Tumor Marker
7%
Tumor Xenograft
7%
Antibody Conjugate
7%
Caveolae
7%
Hypocholesterolemic Agent
7%
Pharmacology, Toxicology and Pharmaceutical Science
Epidermal Growth Factor Receptor 2
100%
Gamma Urogastrone
100%
Stomach Tumor
100%
Pertuzumab
100%
Neoplasm
35%
Mevinolin
35%
Stomach Cancer
14%
Malignant Neoplasm
7%
Dimer
7%
Tracer
7%
Tumor Marker
7%
Antibody Conjugate
7%
Hypocholesterolemic Agent
7%